Baidu
map

高龄患者行皮牵引谨防并发症

2013-07-27 河南驻马店市第四人民医院 张凤霞 健康报

   患者,男,84岁,神志模糊,形体消瘦,重度营养不良,以头痛头晕七天、摔伤髋部右侧肢体功能障碍一天余入住骨科。辅检示脑梗死、脑萎缩、右侧股骨颈转子间骨折。因患者属高龄,不宜手术而行右下肢皮牵引。   牵引一周后患者出现表情淡漠,右踝部皮肤发黑坏死,右侧肢体瘫痪,双侧巴氏征(﹢),复查示双肺感染,右基底节区腔隙性脑梗死、左颞顶叶脑梗死。后转入内科继续皮牵引,给予抗感染、抗血小

   患者,男,84岁,神志模糊,形体消瘦,重度营养不良,以头痛头晕七天、摔伤髋部右侧肢体功能障碍一天余入住骨科。辅检示脑梗死、脑萎缩、右侧股骨颈转子间骨折。因患者属高龄,不宜手术而行右下肢皮牵引。

  牵引一周后患者出现表情淡漠,右踝部皮肤发黑坏死,右侧肢体瘫痪,双侧巴氏征(﹢),复查示双肺感染,右基底节区腔隙性脑梗死、左颞顶叶脑梗死。后转入内科继续皮牵引,给予抗感染、抗血小板聚集、改善循环等治疗后患者病情好转,但右下肢局部情况出现恶化:右侧足背动脉搏动消失,皮温下降,右足背及踝关节、足跟发绀,足背有一3mm×5mm水泡及渗出,拇指、第二及中趾缺血缺氧,继而干燥发黑。经停止牵引,对症处理,局部情况好转。

  体会:患者右侧肢体骨折,加之年老感觉迟钝,形体消瘦,脑梗死致右侧肢体瘫痪,皮牵引护理不当等多重因素,导致患者出现右踝部压疮、右足趾缺血性坏死等并发症,使患者饱受疾病折磨,极易引发医患纠纷。



    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1757577, encodeId=030d1e575779a, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Sep 10 08:46:00 CST 2013, time=2013-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045947, encodeId=6053204594e6e, content=<a href='/topic/show?id=1f1410283499' target=_blank style='color:#2F92EE;'>#高龄患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102834, encryptionId=1f1410283499, topicName=高龄患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Nov 09 14:46:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416019, encodeId=009a1416019eb, content=<a href='/topic/show?id=99fb1028231b' target=_blank style='color:#2F92EE;'>#高龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102823, encryptionId=99fb1028231b, topicName=高龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307c3130149, createdName=xlysu, createdTime=Mon Jul 29 01:46:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2013-09-10 丁鹏鹏
  2. [GetPortalCommentsPageByObjectIdResponse(id=1757577, encodeId=030d1e575779a, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Sep 10 08:46:00 CST 2013, time=2013-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045947, encodeId=6053204594e6e, content=<a href='/topic/show?id=1f1410283499' target=_blank style='color:#2F92EE;'>#高龄患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102834, encryptionId=1f1410283499, topicName=高龄患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Nov 09 14:46:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416019, encodeId=009a1416019eb, content=<a href='/topic/show?id=99fb1028231b' target=_blank style='color:#2F92EE;'>#高龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102823, encryptionId=99fb1028231b, topicName=高龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307c3130149, createdName=xlysu, createdTime=Mon Jul 29 01:46:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1757577, encodeId=030d1e575779a, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Tue Sep 10 08:46:00 CST 2013, time=2013-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045947, encodeId=6053204594e6e, content=<a href='/topic/show?id=1f1410283499' target=_blank style='color:#2F92EE;'>#高龄患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102834, encryptionId=1f1410283499, topicName=高龄患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Nov 09 14:46:00 CST 2013, time=2013-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416019, encodeId=009a1416019eb, content=<a href='/topic/show?id=99fb1028231b' target=_blank style='color:#2F92EE;'>#高龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102823, encryptionId=99fb1028231b, topicName=高龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307c3130149, createdName=xlysu, createdTime=Mon Jul 29 01:46:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2013-07-29 xlysu
Baidu
map
Baidu
map
Baidu
map